Associated Papers
Somatic Mutations of Thymic Epithelial Tumors Identified in the Prospective THYMOGENE Trial.
Pardini E et al.
Thoracic Cancer, 2025
Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies.
Woolston DW et al.
Haematologica, 2024
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.
López-Oreja I et al.
Hemasphere, 2023
Responses to the Tepotinib in Gastric Cancers with MET Amplification or MET Exon 14 Skipping Mutations and High Expression of Both PD-L1 and CD44.
Sohn SH et al.
Cancers, 2022
Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP et al.
Cold Spring Harbor Molecular Case Studies, 2018
Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder.
Hess J et al.
Journal of Cancer Research and Clinical Oncology, 2017
BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia.
Guillem V et al.
Leukemia Research, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
Shankar GM et al.
Acta Neuropathologica Communications, 2014
Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.
Xu P et al.
Plos One, 2013
Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients.
Shaker OG et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2011
BCL2 Ala43Thr is a functional variant associated with protection against azoospermia in a Han-Chinese population.
Ma J et al.
Biology of Reproduction, 2010
BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients.
Moon JH et al.
Leukemia Research, 2010
Mutational analysis in 119 families with nephronophthisis.
O'Toole JF et al.
Pediatric Nephrology (berlin, Germany), 2007
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H et al.
Blood, 2007
Germline BCL-2 sequence variants and inherited predisposition to prostate cancer.
Kidd LR et al.
Prostate Cancer and Prostatic Diseases, 2006
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
Park BL et al.
Journal of Human Genetics, 2004